MedPath

Miasmatic Study of Carbon Group and its Clinical Verificatio

Phase 3
Conditions
Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Registration Number
CTRI/2024/04/065624
Lead Sponsor
DR MISHANGI GIRISHSINH JADEJA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The cases where Carbo Animalis Carbo vegetabilis Graphites

Petroleum Kreosotum Naphthalin glonoinum acedum aceticum were indicated

The cases of all race and

religion will be included

The cases of all socio-economic

conditions will be included

CASES WHICH WILL BE CHRONIC IN NATURE

PATIENTS WHICH HAVE

HISTORY OF RECURRENCY

Exclusion Criteria

The cases with advanced systemic disease will be excluded

The cases with irreversible pathology will be excluded

Female cases with pregnancy will be excluded

Patients who will not give the proper history

Patients with severe systemic and irreversible pathology or deformity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measure Yourself Medical Outcome ProfileTimepoint: Every 7-15 days or as per requirement of cases <br/ ><br>till 9 months
Secondary Outcome Measures
NameTimeMethod
ot ApplicableTimepoint: Not Applicable
© Copyright 2025. All Rights Reserved by MedPath